Elsevier

Brain Research

Volume 1208, 7 May 2008, Pages 67-73
Brain Research

Research Report
Neuregulin blocks synaptic strengthening after epileptiform activity in the rat hippocampus

https://doi.org/10.1016/j.brainres.2008.02.045Get rights and content

Abstract

Synaptic strengthening produced by epileptiform activity may contribute to seizure progression and cognitive impairment in epilepsy. Agents that limit this form of plasticity may have therapeutic benefit. Neuregulin is an endogenous growth factor that is released at synapses in an activity dependent manner and can suppress long term potentiation (LTP). Alterations in neuregulin signaling have been associated with schizophrenia. A role for neuregulin in epilepsy has not been explored. We used field potential recordings to examine the role of neuregulin in regulating synaptic strengthening following epileptiform activity in hippocampal slices. Neuregulin had no effect on basal synaptic transmission, isolated NMDA field potentials or GABAergic inhibition on CA1 pyramidal neurons. However, it reversed LTP at CA1 synapses. Brief exposure to 10 mM potassium chloride produced epileptiform bursting and potentiation of CA1 synapses and suppressed the subsequent induction of LTP. Neuregulin reversed high K+-induced synaptic strengthening, enabling LTP induction after neuregulin washout. In this manner neuregulin preserved the dynamic range of synaptic responses and plasticity after epileptiform activity. These results indicate that LTP and high K+-induced synaptic strengthening share a common neuregulin-sensitive mechanism. By opposing synaptic strengthening caused by epileptiform activity, we suggest that neuregulin may reduce the generation and spread of seizures as well as memory deficits associated with epilepsy.

Introduction

Epilepsy is a common neurological disorder that affects ~ 1% of the population worldwide (Holden et al., 2005). In cases of chronic epilepsy with poorly controlled seizures, the frequency and/or severity of seizures often increases with time and patients can experience progressive cognitive decline (Aldenkamp and Bodde, 2005). The neurological basis by which seizures facilitate subsequent seizures and enhance cognitive decline is the subject of intense investigation. In animal models of epilepsy a number of critical processes have been identified including alterations in synaptic inhibition (Sloviter, 1987), changes in intrinsic excitability (Bernard et al., 2004), cell loss (Naegele, 2007), and axonal sprouting (Sutula et al., 1988).

In addition to these processes, epileptiform activity induces long term potentiation of excitatory synaptic transmission in the hippocampus. In animal models epileptiform activity induced by GABAA antagonists (Schneiderman, 1997, Abegg et al., 2004, Debanne et al., 2006), kainic acid (Ben-Ari and Gho, 1988), high potassium (Fleck et al., 1992, Morgan and Teyler, 2001) and electrical stimulation (Sutula and Steward, 1986, Stasheff et al., 1989) produce long term potentiation (LTP). Synaptic potentiation during epileptiform activity is critical for the subsequent development of spontaneous bursting. Thus, blockade of LTP during epileptiform activity prevents the induction of bursting (Debanne et al., 2006). Strengthening of excitatory synapses appears to be important for the development of seizures because it enhances interactions between excitatory neurons in the hippocampal network. This enhancement of excitatory drive shifts the balance of excitation and inhibition toward excitation, thereby favoring synchronized epileptiform activity (Bains et al., 1999, Staley et al., 2001). Burst-induced potentiation could therefore produce increases in the size of an epileptic focus or facilitate the spread of activity out of a focus. In addition, synaptic strengthening during seizures could interfere with memory mechanisms by occluding or blocking synaptic plasticity required for normal memory function (Schneiderman, 1997, Hsu et al., 2000, Debanne et al., 2006). Strategies aimed at preventing synaptic strengthening caused by seizures may therefore have clinical value.

In this study we have investigated the effect of the growth factor neuregulin on synaptic strengthening produced by epileptiform activity. Neuregulins are a family of growth factors important in early CNS development (Esper et al., 2006). In the adult brain the function of neuregulin is poorly understood although increasing evidence implicates neuregulin as one of the susceptibility genes for schizophrenia (Owen et al., 2005). Neuregulin-1 (NRG1) and its ErbB tyrosine kinase receptors (ErbB 1–4) are highly expressed in the adult brain, including hippocampal pyramidal neurons (Garcia et al., 2000, Huang et al., 2000, Law et al., 2004). Neuregulin accumulates at central synapses and is released in an activity dependent manner (Ozaki et al., 2004). Kainic acid induced seizures, forced locomotion and tetanic stimulation transiently upregulate neuregulin release and ErbB expression (Eilam et al., 1998, Loeb et al., 2002). In adult brain, ErbB and NMDA receptors colocalize at glutamatergic synapses and interact with PDZ-domain scaffolding proteins (Garcia et al., 2000, Huang et al., 2000). Neuregulin suppresses synaptic plasticity. At Schaffer collateral synapses on CA1 pyramidal neurons NRG1β prevents (Huang et al., 2000) or reverses LTP (Kwon et al., 2005). NRG1β has been reported to reverse LTP by promoting internalization of GluR1-containing AMPA receptors at potentiated synapses (Kwon et al., 2005). Based on these findings, we proposed that neuregulin might suppress synaptic strengthening produced by epileptiform activity. We demonstrate that a brief period of high K+-induced epileptiform activity produces synaptic potentiation and suppresses the subsequent induction of LTP. NRG1β blocks synaptic strengthening after epileptiform activity and allows subsequent stimulus trains to induce LTP. These findings indicate a role for neuregulin in limiting plasticity induced by epileptiform activity and suggest that neuregulin may reduce the generation and spread of seizures as well as memory deficits associated with epilepsy.

Section snippets

Neuregulin 1β blocks long term potentiation

To examine the effects of neuregulin on synaptic transmission and plasticity we tested the effect of the NRG1β peptide on fEPSPs recorded in the CA1 region of rat hippocampal slices. The NRG1β peptide contains the EGF domain sufficient for ErbB receptor activation; moreover the β isoform is prevalent in the CNS (Buonanno and Fischbach, 2001). NRG1β (10 nM) had no effect on baseline synaptic transmission (baseline in NRG1β 100 ± 0.2% of control, p = 0.3, n = 4; Fig. 1 A). We then delivered stimulus

Discussion

The principal finding of this study is that neuregulin reversed potentiation after epileptiform activity and preserved the dynamic range of synaptic plasticity at CA1 synapses. Neuregulin suppressed burst-induced potentiation without affecting baseline responses or suppressing fEPSPs below baseline levels. NRG1β did not alter neuronal excitability, NMDA fEPSPs or recurrent GABAergic inhibition, but acted only to reverse activity dependent changes.

The inability of NRG1β to affect paired pulse

Preparation of hippocampal slices

Transverse brain slices (500 μM thick) were prepared from isoflurane-anesthetized male Sprague–Dawley rats (35–42 days old) using a vibratome (Leica VT1000S, Nussloch, Germany). Brain slices were incubated in room temperature ACSF (artificial cerebrospinal fluid) containing (in mM): 125 NaCl, 2.7 KCl, 1.25 NaH2PO4, 25 NaHCO3, 10 glucose, 2 mM CaCl2, 1 mM MgCl2, bubbled with a 95% O2/5% CO2 gas mixture to pH 7.4. Osmolarity was 305 mOsm. Slices were allowed to incubate at least 1 h prior to

Acknowledgments

This work was supported by the South Carolina Research Foundation and the University of South Carolina Research Opportunity Program (DDM).

References (42)

  • MorganS.L. et al.

    Epileptic-like activity induces multiple forms of plasticity in hippocampal area CA1

    Brain Res.

    (2001)
  • OwenM.J. et al.

    Schizophrenia: genes at last?

    Trends Genet.

    (2005)
  • SchneidermanJ.H.

    The role of long-term potentiation in persistent epileptiform burst-induced hyperexcitability following GABAA receptor blockade

    Neuroscience

    (1997)
  • AbeggM.H. et al.

    Epileptiform activity in rat hippocampus strengthens excitatory synapses

    J. Physiol.

    (2004)
  • AldenkampA.P. et al.

    Behaviour, cognition and epilepsy

    Acta Neurol. Scand., Suppl.

    (2005)
  • BainsJ.S. et al.

    Reciprocal interactions between CA3 network activity and strength of recurrent collateral synapses

    Nat. Neurosci.

    (1999)
  • Ben-AriY. et al.

    Long-lasting modification of the synaptic properties of rat CA3 hippocampal neurones induced by kainic acid

    J. Physiol.

    (1988)
  • BernardC. et al.

    Acquired dendritic channelopathy in temporal lobe epilepsy

    Science

    (2004)
  • DebanneD. et al.

    A brief period of epileptiform activity strengthens excitatory synapses in the rat hippocampus in vitro

    Epilepsia

    (2006)
  • EilamR. et al.

    Activity-dependent regulation of Neu differentiation factor/neuregulin expression in rat brain

    Proc. Natl. Acad. Sci. U. S. A.

    (1998)
  • GarciaR.A. et al.

    The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses

    Proc. Natl. Acad. Sci. U. S. A.

    (2000)
  • Cited by (18)

    • Neuregulin 1/ErbB4/Akt signaling attenuates cytotoxicity mediated by the APP-CT31 fragment of amyloid precursor protein

      2021, Experimental and Molecular Pathology
      Citation Excerpt :

      In the adult brain, NRG1 and ErbB4 are abundantly expressed in the cerebral cortex and limbic regions, such as the hippocampus (Eilam et al., 1998; Steiner et al., 1999; Woo et al., 2007). NRG1 and ErbB4 have been implicated in neural development, neurotransmission, synaptic plasticity, and neuronal protection (Iyengar and Mott, 2008; Li et al., 2007; Mei and Xiong, 2008). In a previous study, we reported that NRG1 prevented the Aβ1-42-induced impairment of LTP in hippocampal slices via ErbB4 receptor (Min et al., 2011).

    • Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases

      2014, Neuron
      Citation Excerpt :

      Glutamate has two major inotropic receptors a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) and NMDAR. There is a general consensus that Nrg1 does not change basal synaptic transmission, such as AMPAR- or NMDAR-induced currents in hippocampal CA1 neurons (Bjarnadottir et al., 2007; Chen et al., 2010b; Huang et al., 2001; Iyengar and Mott, 2008) or in cultured cerebellar granule neurons (Fenster et al., 2012). Nevertheless, Nrg1 was shown to reduce AMPAR EPSCs at potentiated synapses, presumably by increasing AMPAR endocytosis in hippocampal neurons.

    • Acute neuregulin-1 signaling influences AMPA receptor mediated responses in cultured cerebellar granule neurons

      2012, Brain Research Bulletin
      Citation Excerpt :

      In the developed nervous system, neuregulin signals through ErbB4 to influence transmission and plasticity at glutamatergic synapses [3,15,17,34]. Specifically, acute activation of NRG1/ErbB4-signaling pathways inhibits both the induction and maintenance of LTP at CA3 → CA1 synapses [15,17,34]. Given the well-established requirement of CA3 → CA1 LTP in hippocampal-dependent learning (reviewed in [41]), understanding the mechanisms through which NRG1 regulates plasticity at these synapses has important implications.

    • The neuregulin signaling pathway and schizophrenia: From genes to synapses and neural circuits

      2010, Brain Research Bulletin
      Citation Excerpt :

      These results are difficult to reconcile with the lack of ErbB4 receptors in these neurons [150] (see above) and with the observation that LTP is enhanced in ErbB4 mutant mice [120]. The weight of evidence instead favors a model in which NRG signaling via ErbB4 receptors suppresses induction and expression of LTP in the hippocampus [81,69,13,80,120,70] and diminishes glutamatergic transmission in cortical neurons [56]. Dopamine is an important modulator of LTP and LTD at glutamatergic synapses throughout the brain (see [74]).

    View all citing articles on Scopus
    View full text